{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T01:52:21Z","timestamp":1791769941843,"version":"4.3.4"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.mam.2021.100999","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T04:12:32Z","timestamp":1627359152000},"page":"100999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Unlocking the bacterial membrane as a therapeutic target for next-generation antimicrobial amphiphiles"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9840-0181","authenticated-orcid":false,"given":"Devashish","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharti","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-8409","authenticated-orcid":false,"given":"Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2021.100999_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/EBC20160063","article-title":"Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria","volume":"61","author":"Arzanlou","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.mam.2021.100999_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/membranes10080181","article-title":"Polymyxins and bacterial membranes: a review of antibacterial activity and mechanisms of resistance","volume":"10","author":"Ayoub Moubareck","year":"2020","journal-title":"Membranes"},{"key":"10.1016\/j.mam.2021.100999_bib3","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1073\/pnas.1717160115","article-title":"Technologies to address antimicrobial resistance","volume":"115","author":"Baker","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.mam.2021.100999_bib4","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1016\/j.bmcl.2008.09.013","article-title":"Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents","volume":"18","author":"Bavikar","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.mam.2021.100999_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad3292","article-title":"Multidrug evolutionary strategies to reverse antibiotic resistance","volume":"351","author":"Baym","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.mam.2021.100999_bib6","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1021\/jm800345u","article-title":"Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity","volume":"51","author":"Bera","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/jac\/dkq083","article-title":"Antibacterial activity of guanidinylated neomycin B- and kanamycin A-derived amphiphilic lipid conjugates","volume":"65","author":"Bera","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2021.100999_bib8","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1021\/jm1000437","article-title":"Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity","volume":"53","author":"Bera","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib9","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.bmcl.2010.03.116","article-title":"Evaluation of amphiphilic aminoglycoside-peptide triazole conjugates as antibacterial agents","author":"Bera","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.mam.2021.100999_bib10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.carres.2011.01.015","article-title":"Synthesis and antibacterial activity of amphiphilic lysine-ligated neomycin B conjugates","volume":"346","author":"Bera","year":"2011","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.mam.2021.100999_bib11","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.3390\/molecules17089129","article-title":"Synthesis and antibacterial activities of amphiphilic neomycin B-based bilipid conjugates and fluorinated neomycin B-based lipids","volume":"17","author":"Bera","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.mam.2021.100999_bib12","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1021\/ol4030138","article-title":"Site-selective displacement of tobramycin hydroxyls for preparation of antimicrobial cationic amphiphiles","volume":"15","author":"Berkov-Zrihen","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.mam.2021.100999_bib13","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1016\/j.bmc.2013.03.046","article-title":"Di-alkylated paromomycin derivatives: targeting the membranes of gram positive pathogens that cause skin infections","volume":"21","author":"Berkov-Zrihen","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/1751-7915.12044","article-title":"Antibiotic adjuvants: identification and clinical use","volume":"6","author":"Bernal","year":"2013","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.mam.2021.100999_bib15","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.2174\/0929867325666180309113737","article-title":"Bile acid derivatives: from old molecules to a new potent therapeutic use: an overview","volume":"25","author":"Blanchet","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment","volume":"14","author":"Brauner","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib17","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/molecules25061340","article-title":"Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.mam.2021.100999_bib18","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1021\/jacs.8b09906","article-title":"Correction to \"dual targeting of intracellular pathogenic bacteria with a cleavable conjugate of kanamycin and an antibacterial cell-penetrating peptide","volume":"140","author":"Brezden","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mam.2021.100999_bib19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrmicro3480","article-title":"Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi","volume":"13","author":"Brown","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(06)91001-3","article-title":"A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens","volume":"91","author":"Casadevall","year":"2006","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.mam.2021.100999_bib21","series-title":"Characterisation of the E. coli and Pseudomonas aeruginosa TolA- TolB Interaction","author":"Cassels","year":"2012"},{"key":"10.1016\/j.mam.2021.100999_bib22","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/nm1116-1197","article-title":"What's old is new: reconfiguring known antibiotics to fight drug resistance","volume":"22","author":"Chakradhar","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.mam.2021.100999_bib23","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1038\/srep06860","article-title":"Synthesis and antibacterial activities of antibacterial peptides with a spiropyran fluorescence probe","volume":"4","author":"Chen","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2021.100999_bib24","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/acsinfecdis.9b00078","article-title":"Synthesis and bioactivities of new membrane-active agents with aromatic linker: high selectivity and broad-spectrum antibacterial activity","volume":"5","author":"Chu","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.mam.2021.100999_bib25","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1039\/C9CC00857H","article-title":"Low-toxicity amphiphilic molecules linked by an aromatic nucleus show broad-spectrum antibacterial activity and low drug resistance","volume":"55","author":"Chu","year":"2019","journal-title":"Chem. Commun. (Camb)."},{"key":"10.1016\/j.mam.2021.100999_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259","article-title":"Gram staining","volume":"3C","author":"Coico","year":"2005","journal-title":"Curr. Protoc. Microbiol. Appendi"},{"key":"10.1016\/j.mam.2021.100999_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1120009X.2017.1380397","article-title":"Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections","volume":"29","author":"Concia","year":"2017","journal-title":"J. Chemother."},{"key":"10.1016\/j.mam.2021.100999_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1128\/br.38.1.87-110.1974","article-title":"Structure and function of the cell envelope of gram-negative bacteria","volume":"38","author":"Costerton","year":"1974","journal-title":"Bacteriol. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib29","first-page":"329","article-title":"Bacteriophage as a treatment in acute medical and surgical infections","volume":"7","author":"d'Herelle","year":"1931","journal-title":"Bull. N. Y. Acad. Med."},{"key":"10.1016\/j.mam.2021.100999_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 million people die a year due to antimicrobial resistance by 2050?","volume":"13","author":"de Kraker","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.mam.2021.100999_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.mam.2021.100999_bib32","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1021\/acs.jmedchem.8b01093","article-title":"Battle against vancomycin-resistant bacteria: recent developments in chemical strategies","volume":"62","author":"Dhanda","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ja.2012.59","article-title":"Antibacterial activity of amphiphilic tobramycin","volume":"65","author":"Dhondikubeer","year":"2012","journal-title":"J. Antibiot."},{"key":"10.1016\/j.mam.2021.100999_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009655","article-title":"A multifunctional bispecific antibody protects against Pseudomonas aeruginosa","volume":"6","author":"DiGiandomenico","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mam.2021.100999_bib35","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1021\/ol048845t","article-title":"Synthesis and characterization of peptide-cationic steroid antibiotic conjugates","volume":"6","author":"Ding","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.mam.2021.100999_bib36","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1021\/ja046909p","article-title":"Origins of cell selectivity of cationic steroid antibiotics","volume":"126","author":"Ding","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mam.2021.100999_bib37","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1039\/C7CC04206J","article-title":"L-Lysine based lipidated biphenyls as agents with anti-biofilm and anti-inflammatory properties that also inhibit intracellular bacteria","volume":"53","author":"Divakara","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.mam.2021.100999_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJM198802183180706","article-title":"Beta-Lactam antibiotics (1)","volume":"318","author":"Donowitz","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2021.100999_bib39","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.1021\/acs.jmedchem.8b01781","article-title":"Antibiotic adjuvants: make antibiotics great again!","volume":"62","author":"Douafer","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1358\/dnp.2008.21.6.1246829","article-title":"Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents","volume":"21","author":"Epand","year":"2008","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.mam.2021.100999_bib41","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.bbamem.2015.10.018","article-title":"Molecular mechanisms of membrane targeting antibiotics","volume":"1858","author":"Epand","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mam.2021.100999_bib42","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2147\/IDR.S169894","article-title":"Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments","volume":"11","author":"Eze","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.mam.2021.100999_bib43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CMR.00043-12","article-title":"Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance","volume":"25","author":"Fern\u00e1ndez","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib44","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.3390\/ijms20204996","article-title":"Folic acid antagonists: antimicrobial and immunomodulating mechanisms and applications","volume":"20","author":"Fern\u00e1ndez-Villa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2021.100999_bib45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/cr030102i","article-title":"Bacterial resistance to beta- lactam antibiotics: compelling opportunism, compelling opportunity","volume":"105","author":"Fisher","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","article-title":"Persistent bacterial infections and persister cells","volume":"15","author":"Fisher","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib47","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1021\/acs.jmedchem.5b01375","article-title":"Synthesis and bioactivities of kanamycin B-derived cationic amphiphiles","volume":"58","author":"Fosso","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib48","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.14202\/vetworld.2019.1735-1746","article-title":"An overview of colistin resistance, mobilized colistin resistance genes dissemination, global responses, and the alternatives to colistin: a review","volume":"12","author":"Gharaibeh","year":"2019","journal-title":"Vet. World"},{"key":"10.1016\/j.mam.2021.100999_bib49","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/jm401680a","article-title":"Small molecular antibacterial peptoid mimics: the simpler the better!","volume":"57","author":"Ghosh","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144094","article-title":"Aryl-alkyl-Lysines: agents that kill planktonic cells, persister cells, biofilms of MRSA and protect mice from skin-infection","volume":"10","author":"Ghosh","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.mam.2021.100999_bib51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/acsinfecdis.5b00092","article-title":"Aryl-alkyl-lysines: membrane-active small molecules active against murine model of burn infection","volume":"2","author":"Ghosh","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.mam.2021.100999_bib52","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1038\/s41598-020-62496-9","article-title":"Aryl-alkyl-lysines: novel agents for treatment of C. difficile infection","volume":"10","author":"Ghosh","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2021.100999_bib53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12879-015-1054-1","article-title":"Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options","volume":"15","author":"Golan","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.mam.2021.100999_bib54","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1021\/ol0062704","article-title":"Preparation and characterization of cholic acid-derived antimicrobial agents with controlled stabilities","volume":"2","author":"Guan","year":"2000","journal-title":"Org. Lett."},{"key":"10.1016\/j.mam.2021.100999_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1756283X15607414","article-title":"Fecal microbiota transplantation: in perspective","volume":"9","author":"Gupta","year":"2016","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.mam.2021.100999_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00520-19","article-title":"Cholic acid-peptide conjugates as potent antimicrobials against interkingdom polymicrobial biofilms","volume":"63","author":"Gupta","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mam.2021.100999_bib57","article-title":"Cholic-acid-derived amphiphiles can prevent and degrade fungal biofilms","author":"Gupta","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.mam.2021.100999_bib58","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1021\/acs.chemrev.7b00522","article-title":"Small bioactive peptides for biomaterials design and therapeutics","volume":"117","author":"Hamley","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib59","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0966-842X(00)01823-0","article-title":"The role of cationic antimicrobial peptides in innate host defences","volume":"8","author":"Hancock","year":"2000","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1039\/C2MD20162C","article-title":"Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity","volume":"4","author":"Herzog","year":"2013","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.mam.2021.100999_bib61","doi-asserted-by":"crossref","first-page":"12225","DOI":"10.1021\/la302303d","article-title":"Cleavable cationic antibacterial amphiphiles: synthesis, mechanism of action, and cytotoxicities","volume":"28","author":"Hoque","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.mam.2021.100999_bib62","doi-asserted-by":"crossref","first-page":"11279","DOI":"10.1039\/C3CP55244F","article-title":"Effect of amide bonds on the self-assembly of gemini surfactants","volume":"16","author":"Hoque","year":"2014","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.mam.2021.100999_bib63","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1021\/acs.jmedchem.5b00443","article-title":"Membrane active small molecules show selective broad spectrum antibacterial activity with No detectable resistance and eradicate biofilms","volume":"58","author":"Hoque","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib64","doi-asserted-by":"crossref","first-page":"10750","DOI":"10.1021\/acs.jmedchem.6b01435","article-title":"Antibacterial and antibiofilm activity of cationic small molecules with spatial positioning of hydrophobicity: an in vitro and in vivo evaluation","volume":"59","author":"Hoque","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib65","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cmi.2019.11.028","article-title":"Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage","volume":"26","author":"Huttner","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mam.2021.100999_bib66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejps.2013.07.005","article-title":"N-cholesteryl amino acid conjugates and their antimicrobial activities","volume":"50","author":"Jadhav","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.mam.2021.100999_bib67","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ijantimicag.2016.11.029","article-title":"Resistance to polymyxins in Gram- negative organisms","volume":"49","author":"Jeannot","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.mam.2021.100999_bib68","doi-asserted-by":"crossref","first-page":"12900","DOI":"10.1021\/acs.langmuir.0c02135","article-title":"Physicochemical and biological characterization of novel membrane-active cationic lipopeptides with antimicrobial properties","volume":"36","author":"Juhaniewicz-D\u0119bi\u0144ska","year":"2020","journal-title":"Langmuir"},{"key":"10.1016\/j.mam.2021.100999_bib69","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/cr030103a","article-title":"Glycopeptide and lipoglycopeptide antibiotics","volume":"105","author":"Kahne","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib70","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/joacp.JOACP_349_15","article-title":"Action and resistance mechanisms of antibiotics: a guide for clinicians","volume":"33","author":"Kapoor","year":"2017","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"10.1016\/j.mam.2021.100999_bib71","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1021\/bi702232a","article-title":"Vancomycin derivative with damaged D-Ala-D-Ala binding cleft binds to cross-linked peptidoglycan in the cell wall of Staphylococcus aureus","volume":"47","author":"Kim","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.mam.2021.100999_bib72","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/jm501285x","article-title":"Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections","volume":"58","author":"Koh","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib73","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/acsinfecdis.5b00056","article-title":"Lysine-based small molecules that disrupt biofilms and kill both actively growing planktonic and nondividing stationary phase bacteria","volume":"1","author":"Konai","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.mam.2021.100999_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/acsinfecdis.9b00221","article-title":"Lysine-based small molecule sensitizes rifampicin and tetracycline against multidrug-resistant acinetobacter baumannii and Pseudomonas aeruginosa","volume":"6","author":"Konai","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.mam.2021.100999_bib75","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: an overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb. Perspect Med."},{"key":"10.1016\/j.mam.2021.100999_bib76","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1101\/gad.1299905","article-title":"Bacterial outer membrane vesicles and the host-pathogen interaction","volume":"19","author":"Kuehn","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.mam.2021.100999_bib77","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1021\/acsbiomaterials.9b00706","article-title":"Cholic acid-derived amphiphile which combats gram-positive bacteria-mediated infections via disintegration of lipid clusters","volume":"5","author":"Kumar","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.mam.2021.100999_bib78","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/ar700270t","article-title":"Ceragenins: cholic acid-based mimics of antimicrobial peptides","volume":"41","author":"Lai","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.mam.2021.100999_bib79","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/ar700270t","article-title":"Ceragenins: cholic acid-based mimics of antimicrobial peptides","volume":"41","author":"Lai","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.mam.2021.100999_bib80","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41564-018-0164-0","article-title":"Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides","volume":"3","author":"L\u00e1z\u00e1r","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrmicro976","article-title":"Primate defensins","volume":"2","author":"Lehrer","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib82","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/ja973881r","article-title":"Design and synthesis of potent sensitizers of Gram-negative bacteria based on a cholic acid scaffolding","volume":"120","author":"Li","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mam.2021.100999_bib83","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/ja982938m","article-title":"Incremental conversion of outer-membrane permeabilizers into potent antibiotics for Gram-negative bacteria","volume":"121","author":"Li","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mam.2021.100999_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112596","article-title":"Design, synthesis, and evaluation of amphiphilic sofalcone derivatives as potent Gram-positive antibacterial agents","volume":"202","author":"Lin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib85","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib86","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1365-2958.2006.05317.x","article-title":"Lipid domains in bacterial membranes","volume":"61","author":"Matsumoto","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fmicb.2019.00041","article-title":"Drug repurposing for the treatment of bacterial and fungal infections","volume":"10","author":"Mir\u00f3-Canturri","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib88","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1039\/C9MD00166B","article-title":"Rational design of novel amphipathic antimicrobial peptides focused on the distribution of cationic amino acid residues","volume":"10","author":"Misawa","year":"2019","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.mam.2021.100999_bib89","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acs.jpclett.8b03508","article-title":"Distinct intramolecular hydrogen bonding dictates antimicrobial action of membrane-targeting amphiphiles","volume":"10","author":"Mitra","year":"2019","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.mam.2021.100999_bib90","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bbagen.2017.01.029","article-title":"Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate","volume":"1861","author":"Mohamed","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.mam.2021.100999_bib91","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cpdd.410","article-title":"Safety, pharmacokinetics, and immunogenicity of obiltoxaximab after intramuscular administration to healthy humans","volume":"7","author":"Nagy","year":"2018","journal-title":"Clin. Pharmacol. Drug. Dev."},{"key":"10.1016\/j.mam.2021.100999_bib92","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrmicro3047","article-title":"Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis","volume":"11","author":"Needham","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib93","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/br.20.1.14-27.1956","article-title":"The properties and mode of action of the polymyxins","volume":"20","author":"Newton","year":"1956","journal-title":"Bacteriol. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib94","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/scdb.2000.0247","article-title":"Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria","volume":"12","author":"Nikaido","year":"2001","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.mam.2021.100999_bib95","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","article-title":"Molecular basis of bacterial outer membrane permeability revisited","volume":"67","author":"Nikaido","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib96","doi-asserted-by":"crossref","first-page":"E5052","DOI":"10.1073\/pnas.1704125114","article-title":"Peripheral modifications of [\u03a8[CH2NH]Tpg4]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics","volume":"114","author":"Okano","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.mam.2021.100999_bib97","author":"pewtrusts"},{"key":"10.1016\/j.mam.2021.100999_bib98","doi-asserted-by":"crossref","first-page":"17220","DOI":"10.1021\/acsami.0c01167","article-title":"Gemini peptide amphiphiles with broad-spectrum antimicrobial activity and potent antibiofilm capacity","volume":"12","author":"Qi","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mam.2021.100999_bib99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/dku320","article-title":"Polymorphism of genes encoding PmrAB in colistin-resistant strains of Escherichia coli and Salmonella enterica isolated from poultry and swine","volume":"70","author":"Quesada","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2021.100999_bib100","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/IJMR.2010_132_05_478","article-title":"New metallo \u03b2-lactamase NDM-1","volume":"132","author":"Raghunath","year":"2010","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.mam.2021.100999_bib101","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.3389\/fmicb.2019.02866","article-title":"Mechanisms of action for antimicrobial peptides with antibacterial and antibiofilm functions","volume":"10","author":"Raheem","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07651-7","article-title":"Macromolecular-clustered facial amphiphilic antimicrobials","volume":"9","author":"Rahman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2021.100999_bib103","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1021\/acsami.8b17808","article-title":"Design, synthesis, and nanostructure-dependent antibacterial activity of cationic peptide amphiphiles","volume":"11","author":"Rodrigues de Almeida","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mam.2021.100999_bib104","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fimmu.2020.01048","article-title":"Vaccines against antimicrobial resistance","volume":"11","author":"Rosini","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2021.100999_bib105","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/acschembio.0c00091","article-title":"Vancomycin derivative inactivates carbapenem-resistant acinetobacter baumannii and induces autophagy","volume":"15","author":"Sarkar","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.mam.2021.100999_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2002.tb11448.x","article-title":"Antibacterial properties of cationic steroid antibiotics","volume":"217","author":"Savage","year":"2002","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.mam.2021.100999_bib107","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.7701329","article-title":"Structure of the cell wall anchor of surface proteins in Staphylococcus aureus","volume":"268","author":"Schneewind","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.mam.2021.100999_bib108","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Outer-membrane vesicles from Gram- negative bacteria: biogenesis and functions","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib109","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.mi.37.100183.002441","article-title":"Structure, function, and assembly of cell walls of gram-positive bacteria","volume":"37","author":"Shockman","year":"1983","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges of antibacterial discovery","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib111","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1021\/acs.jmedchem.8b01433","article-title":"Bile acid oligomers and their combination with antibiotics to combat bacterial infections","volume":"61","author":"Singla","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib112","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1021\/acsomega.9b03425","article-title":"Facially amphiphilic cholic acid\u2013lysine conjugates as promising antimicrobials","volume":"5","author":"Singla","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.mam.2021.100999_bib113","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1054\/drup.2000.0146","article-title":"Sulfonamide resistance: mechanisms and trends","volume":"3","author":"Sk\u00f6ld","year":"2000","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.mam.2021.100999_bib114","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41564-020-0723-z","article-title":"A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens","volume":"5","author":"Song","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib115","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41564-020-0723-z","article-title":"A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens","volume":"5","author":"Song","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib116","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/524891","article-title":"The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America","volume":"46","author":"Spellberg","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mam.2021.100999_bib117","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3163\/1536-5050.97.4.002","article-title":"National Institutes of Health public access policy assistance: one library's approach","volume":"97","author":"Stimson","year":"2009","journal-title":"J. Med. Libr. Assoc."},{"key":"10.1016\/j.mam.2021.100999_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jbiotec.2014.09.003","article-title":"Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies","volume":"191","author":"Taylor","year":"2014","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.mam.2021.100999_bib121","first-page":"275","article-title":"The global preclinical antibacterial pipeline","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib122","article-title":"Strategies to combat antimicrobial resistance","volume":"8","author":"Uchil","year":"2014","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.mam.2021.100999_bib123","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1039\/C6CS00270F","article-title":"Teichoic acids: synthesis and applications","volume":"46","author":"van der Es","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib124","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41579-019-0294-2","article-title":"Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria","volume":"18","author":"Vergalli","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/dkg050","article-title":"The importance of efflux pumps in bacterial antibiotic resistance","volume":"51","author":"Webber","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2021.100999_bib126","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/marc.201200534","article-title":"Rationally designed \u03b1\u2010helical broad\u2010spectrum antimicrobial peptides with idealized facial amphiphilicity","volume":"34","author":"Wiradharma","year":"2013","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.mam.2021.100999_bib127","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/ml200290p","article-title":"Small molecule suppression of carbapenem resistance in NDM-1 producing Klebsiella pneumoniae","volume":"3","author":"Worthington","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.mam.2021.100999_bib128","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.addr.2005.04.002","article-title":"Bacterial resistance to antibiotics: enzymatic degradation and modification","volume":"57","author":"Wright","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mam.2021.100999_bib129","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1039\/c0cc05111j","article-title":"Molecular mechanisms of antibiotic resistance","volume":"47","author":"Wright","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.mam.2021.100999_bib130","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.tim.2016.07.008","article-title":"Antibiotic adjuvants: rescuing antibiotics from resistance","volume":"24","author":"Wright","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.mam.2021.100999_bib131","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1021\/acs.jmedchem.8b01357","article-title":"Deciphering the role of intramolecular networking in cholic acid-peptide conjugates on the lipopolysaccharide surface in combating gram-negative bacterial infections","volume":"62","author":"Yadav","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib132","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/acs.bioconjchem.8b00880","article-title":"Oral delivery of cholic acid-derived amphiphile helps in combating salmonella-mediated gut infection and inflammation","volume":"30","author":"Yadav","year":"2019","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.mam.2021.100999_bib133","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1021\/jm500270w","article-title":"Membrane active vancomycin analogues: a strategy to combat bacterial resistance","volume":"57","author":"Yarlagadda","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mam.2021.100999_bib134","doi-asserted-by":"crossref","first-page":"13644","DOI":"10.1002\/anie.201507567","article-title":"Membrane disruption and enhanced inhibition of cell-wall biosynthesis: a synergistic approach to tackle vancomycin-resistant bacteria","volume":"54","author":"Yarlagadda","year":"2015","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.mam.2021.100999_bib135","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1002\/anie.201601621","article-title":"A vancomycin derivative with a pyrophosphate-binding group: a strategy to combat vancomycin-resistant bacteria","volume":"55","author":"Yarlagadda","year":"2016","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.mam.2021.100999_bib136","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1021\/acsinfecdis.8b00011","article-title":"Vancomycin analogue restores meropenem activity against NDM-1 gram-negative pathogens","volume":"4","author":"Yarlagadda","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.mam.2021.100999_bib137","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mam.2021.100999_bib138","doi-asserted-by":"crossref","first-page":"9421","DOI":"10.1021\/acs.jmedchem.0c00583","article-title":"Rational avoidance of protease cleavage sites and symmetrical end-tagging significantly enhances the stability and therapeutic potential of antimicrobial peptides","volume":"63","author":"Zhu","year":"2020","journal-title":"J. Med. Chem."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299721000595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299721000595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:15:14Z","timestamp":1758824114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299721000595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":137,"alternative-id":["S0098299721000595"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2021.100999","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking the bacterial membrane as a therapeutic target for next-generation antimicrobial amphiphiles","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2021.100999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100999"}}